Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Apr;27(2):193-200.
doi: 10.1097/MOP.0000000000000195.

Autosomal dominant polycystic kidney disease in children

Melissa A Cadnapaphornchai  1
Affiliations
Review

Autosomal dominant polycystic kidney disease in children

Melissa A Cadnapaphornchai. Curr Opin Pediatr. 2015 Apr.

Abstract

Purpose of review: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary renal disease, affecting one in 500 individuals. The cardinal manifestation of ADPKD is progressive cystic dilatation of renal tubules with kidney enlargement and progression to end-stage renal disease in approximately half of cases by 60 years of age. Although previously considered a condition of adults, it is clear that children and young adults are subject to the complications of ADPKD.

Recent findings: It has been increasingly recognized that interventions early in life are necessary in order to confer the best long-term outcome in this common condition. Therefore, it is imperative for pediatricians to recognize the manifestations and complications of this disease. Until recently ADPKD management focused on general principles of chronic kidney disease. However, several recent clinical trials in children and adults with ADPKD have focused on disease-specific therapies.

Summary: This review will highlight the clinical manifestations, diagnosis, and appropriate management of ADPKD in childhood and will review recent relevant clinical trials in children and adults with this condition.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None.

References

    1. United States Renal Data System. 2014 annual data report:an overview of the epidemiology of kidney disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2014.
    1. Pretorius DH, Lee ME, Manco-Johnson ML, et al. Diagnosis of autosomal dominant polycystic kidney disease in utero and in the young infant. J Ultrasound Med. 1987;6:249–255. - PubMed
    1. MacDermot KD, Saggar-Malik AK, Economides DL, Jeffery S. Prenatal diagnosis of autosomal dominant polycystic kidney disease (PKD1) presenting in utero and prognosis for very early onset disease. J Med Genet. 1998;35:13–16. - PMC - PubMed
    1. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med. 1993;329:332–342. - PubMed
    1. Ecder T, Fick-Brosnahan G, Schrier RW. Polycystic kidney disease. In: Schrier RW, editor. Diseases of the kidney and urinary tract. 8th. Philadelphia: Lippincott Williams & Wilkins; 2007. pp. 502–539.

MeSH terms

Substances